table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Infectious Vaccines Market Size Analysis from 2022 to 2027
1.5.1 Global Infectious Vaccines Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Infectious Vaccines Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Infectious Vaccines Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Infectious Vaccines Industry Impact
Chapter 2 Global Infectious Vaccines Competition by Types, Applications, and Top Regions and Countries
2.1 Global Infectious Vaccines (Volume and Value) by Type
2.1.1 Global Infectious Vaccines Consumption and Market Share by Type (2016-2021)
2.1.2 Global Infectious Vaccines Revenue and Market Share by Type (2016-2021)
2.2 Global Infectious Vaccines (Volume and Value) by Application
2.2.1 Global Infectious Vaccines Consumption and Market Share by Application (2016-2021)
2.2.2 Global Infectious Vaccines Revenue and Market Share by Application (2016-2021)
2.3 Global Infectious Vaccines (Volume and Value) by Regions
2.3.1 Global Infectious Vaccines Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Infectious Vaccines Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Infectious Vaccines Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Infectious Vaccines Consumption by Regions (2016-2021)
4.2 North America Infectious Vaccines Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Infectious Vaccines Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Infectious Vaccines Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Infectious Vaccines Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Infectious Vaccines Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Infectious Vaccines Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Infectious Vaccines Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Infectious Vaccines Sales, Consumption, Export, Import (2016-2021)
4.10 South America Infectious Vaccines Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Infectious Vaccines Market Analysis
5.1 North America Infectious Vaccines Consumption and Value Analysis
5.1.1 North America Infectious Vaccines Market Under COVID-19
5.2 North America Infectious Vaccines Consumption Volume by Types
5.3 North America Infectious Vaccines Consumption Structure by Application
5.4 North America Infectious Vaccines Consumption by Top Countries
5.4.1 United States Infectious Vaccines Consumption Volume from 2016 to 2021
5.4.2 Canada Infectious Vaccines Consumption Volume from 2016 to 2021
5.4.3 Mexico Infectious Vaccines Consumption Volume from 2016 to 2021
Chapter 6 East Asia Infectious Vaccines Market Analysis
6.1 East Asia Infectious Vaccines Consumption and Value Analysis
6.1.1 East Asia Infectious Vaccines Market Under COVID-19
6.2 East Asia Infectious Vaccines Consumption Volume by Types
6.3 East Asia Infectious Vaccines Consumption Structure by Application
6.4 East Asia Infectious Vaccines Consumption by Top Countries
6.4.1 China Infectious Vaccines Consumption Volume from 2016 to 2021
6.4.2 Japan Infectious Vaccines Consumption Volume from 2016 to 2021
6.4.3 South Korea Infectious Vaccines Consumption Volume from 2016 to 2021
Chapter 7 Europe Infectious Vaccines Market Analysis
7.1 Europe Infectious Vaccines Consumption and Value Analysis
7.1.1 Europe Infectious Vaccines Market Under COVID-19
7.2 Europe Infectious Vaccines Consumption Volume by Types
7.3 Europe Infectious Vaccines Consumption Structure by Application
7.4 Europe Infectious Vaccines Consumption by Top Countries
7.4.1 Germany Infectious Vaccines Consumption Volume from 2016 to 2021
7.4.2 UK Infectious Vaccines Consumption Volume from 2016 to 2021
7.4.3 France Infectious Vaccines Consumption Volume from 2016 to 2021
7.4.4 Italy Infectious Vaccines Consumption Volume from 2016 to 2021
7.4.5 Russia Infectious Vaccines Consumption Volume from 2016 to 2021
7.4.6 Spain Infectious Vaccines Consumption Volume from 2016 to 2021
7.4.7 Netherlands Infectious Vaccines Consumption Volume from 2016 to 2021
7.4.8 Switzerland Infectious Vaccines Consumption Volume from 2016 to 2021
7.4.9 Poland Infectious Vaccines Consumption Volume from 2016 to 2021
Chapter 8 South Asia Infectious Vaccines Market Analysis
8.1 South Asia Infectious Vaccines Consumption and Value Analysis
8.1.1 South Asia Infectious Vaccines Market Under COVID-19
8.2 South Asia Infectious Vaccines Consumption Volume by Types
8.3 South Asia Infectious Vaccines Consumption Structure by Application
8.4 South Asia Infectious Vaccines Consumption by Top Countries
8.4.1 India Infectious Vaccines Consumption Volume from 2016 to 2021
8.4.2 Pakistan Infectious Vaccines Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Infectious Vaccines Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Infectious Vaccines Market Analysis
9.1 Southeast Asia Infectious Vaccines Consumption and Value Analysis
9.1.1 Southeast Asia Infectious Vaccines Market Under COVID-19
9.2 Southeast Asia Infectious Vaccines Consumption Volume by Types
9.3 Southeast Asia Infectious Vaccines Consumption Structure by Application
9.4 Southeast Asia Infectious Vaccines Consumption by Top Countries
9.4.1 Indonesia Infectious Vaccines Consumption Volume from 2016 to 2021
9.4.2 Thailand Infectious Vaccines Consumption Volume from 2016 to 2021
9.4.3 Singapore Infectious Vaccines Consumption Volume from 2016 to 2021
9.4.4 Malaysia Infectious Vaccines Consumption Volume from 2016 to 2021
9.4.5 Philippines Infectious Vaccines Consumption Volume from 2016 to 2021
9.4.6 Vietnam Infectious Vaccines Consumption Volume from 2016 to 2021
9.4.7 Myanmar Infectious Vaccines Consumption Volume from 2016 to 2021
Chapter 10 Middle East Infectious Vaccines Market Analysis
10.1 Middle East Infectious Vaccines Consumption and Value Analysis
10.1.1 Middle East Infectious Vaccines Market Under COVID-19
10.2 Middle East Infectious Vaccines Consumption Volume by Types
10.3 Middle East Infectious Vaccines Consumption Structure by Application
10.4 Middle East Infectious Vaccines Consumption by Top Countries
10.4.1 Turkey Infectious Vaccines Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Infectious Vaccines Consumption Volume from 2016 to 2021
10.4.3 Iran Infectious Vaccines Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Infectious Vaccines Consumption Volume from 2016 to 2021
10.4.5 Israel Infectious Vaccines Consumption Volume from 2016 to 2021
10.4.6 Iraq Infectious Vaccines Consumption Volume from 2016 to 2021
10.4.7 Qatar Infectious Vaccines Consumption Volume from 2016 to 2021
10.4.8 Kuwait Infectious Vaccines Consumption Volume from 2016 to 2021
10.4.9 Oman Infectious Vaccines Consumption Volume from 2016 to 2021
Chapter 11 Africa Infectious Vaccines Market Analysis
11.1 Africa Infectious Vaccines Consumption and Value Analysis
11.1.1 Africa Infectious Vaccines Market Under COVID-19
11.2 Africa Infectious Vaccines Consumption Volume by Types
11.3 Africa Infectious Vaccines Consumption Structure by Application
11.4 Africa Infectious Vaccines Consumption by Top Countries
11.4.1 Nigeria Infectious Vaccines Consumption Volume from 2016 to 2021
11.4.2 South Africa Infectious Vaccines Consumption Volume from 2016 to 2021
11.4.3 Egypt Infectious Vaccines Consumption Volume from 2016 to 2021
11.4.4 Algeria Infectious Vaccines Consumption Volume from 2016 to 2021
11.4.5 Morocco Infectious Vaccines Consumption Volume from 2016 to 2021
Chapter 12 Oceania Infectious Vaccines Market Analysis
12.1 Oceania Infectious Vaccines Consumption and Value Analysis
12.2 Oceania Infectious Vaccines Consumption Volume by Types
12.3 Oceania Infectious Vaccines Consumption Structure by Application
12.4 Oceania Infectious Vaccines Consumption by Top Countries
12.4.1 Australia Infectious Vaccines Consumption Volume from 2016 to 2021
12.4.2 New Zealand Infectious Vaccines Consumption Volume from 2016 to 2021
Chapter 13 South America Infectious Vaccines Market Analysis
13.1 South America Infectious Vaccines Consumption and Value Analysis
13.1.1 South America Infectious Vaccines Market Under COVID-19
13.2 South America Infectious Vaccines Consumption Volume by Types
13.3 South America Infectious Vaccines Consumption Structure by Application
13.4 South America Infectious Vaccines Consumption Volume by Major Countries
13.4.1 Brazil Infectious Vaccines Consumption Volume from 2016 to 2021
13.4.2 Argentina Infectious Vaccines Consumption Volume from 2016 to 2021
13.4.3 Columbia Infectious Vaccines Consumption Volume from 2016 to 2021
13.4.4 Chile Infectious Vaccines Consumption Volume from 2016 to 2021
13.4.5 Venezuela Infectious Vaccines Consumption Volume from 2016 to 2021
13.4.6 Peru Infectious Vaccines Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Infectious Vaccines Consumption Volume from 2016 to 2021
13.4.8 Ecuador Infectious Vaccines Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Infectious Vaccines Business
14.1 CSL Limited (Australia)
14.1.1 CSL Limited (Australia) Company Profile
14.1.2 CSL Limited (Australia) Infectious Vaccines Product Specification
14.1.3 CSL Limited (Australia) Infectious Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Bavarian Nordic (Denmark)
14.2.1 Bavarian Nordic (Denmark) Company Profile
14.2.2 Bavarian Nordic (Denmark) Infectious Vaccines Product Specification
14.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 GlaxoSmithKline plc. (U.K.)
14.3.1 GlaxoSmithKline plc. (U.K.) Company Profile
14.3.2 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Specification
14.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Emergent Bio Solutions Inc. (U.S.)
14.4.1 Emergent Bio Solutions Inc. (U.S.) Company Profile
14.4.2 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Specification
14.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 MedImmune LLC (U.S.)
14.5.1 MedImmune LLC (U.S.) Company Profile
14.5.2 MedImmune LLC (U.S.) Infectious Vaccines Product Specification
14.5.3 MedImmune LLC (U.S.) Infectious Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Johnson and Johnson (U.S.)
14.6.1 Johnson and Johnson (U.S.) Company Profile
14.6.2 Johnson and Johnson (U.S.) Infectious Vaccines Product Specification
14.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Novartis AG (Switzerland)
14.7.1 Novartis AG (Switzerland) Company Profile
14.7.2 Novartis AG (Switzerland) Infectious Vaccines Product Specification
14.7.3 Novartis AG (Switzerland) Infectious Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Merck and Company (U.S.)
14.8.1 Merck and Company (U.S.) Company Profile
14.8.2 Merck and Company (U.S.) Infectious Vaccines Product Specification
14.8.3 Merck and Company (U.S.) Infectious Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Sanofi Pasteur (France)
14.9.1 Sanofi Pasteur (France) Company Profile
14.9.2 Sanofi Pasteur (France) Infectious Vaccines Product Specification
14.9.3 Sanofi Pasteur (France) Infectious Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Pfizer Inc. (U.S.)
14.10.1 Pfizer Inc. (U.S.) Company Profile
14.10.2 Pfizer Inc. (U.S.) Infectious Vaccines Product Specification
14.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Infectious Vaccines Market Forecast (2022-2027)
15.1 Global Infectious Vaccines Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Infectious Vaccines Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Infectious Vaccines Value and Growth Rate Forecast (2022-2027)
15.2 Global Infectious Vaccines Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Infectious Vaccines Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Infectious Vaccines Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Infectious Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Infectious Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Infectious Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Infectious Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Infectious Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Infectious Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Infectious Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Infectious Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Infectious Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Infectious Vaccines Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Infectious Vaccines Consumption Forecast by Type (2022-2027)
15.3.2 Global Infectious Vaccines Revenue Forecast by Type (2022-2027)
15.3.3 Global Infectious Vaccines Price Forecast by Type (2022-2027)
15.4 Global Infectious Vaccines Consumption Volume Forecast by Application (2022-2027)
15.5 Infectious Vaccines Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
